The latest research report from the IMARC group, titled “smart inhaler market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027”, offers a detailed analysis of the market drivers, segmentation, growth opportunities, trends and competitive landscape to understand the current and future market scenarios.
The global smart inhaler market reached a value of US$162.75 million in 2021. Going forward, IMARC Group expects the market to reach a value of US$630.25 million by 2027, growing at a CAGR of 27.30% over the period 2022-2027. Smart inhalers refer to devices used to deliver a wide range of medications by inhalation. They work by monitoring dose-per-take and inhaler technique of medications, sending reminders, and sensing patients’ surroundings via attached clip-on sensors. This data is then shared with the patient and healthcare professionals via Bluetooth through an online platform that tracks their use of the inhaler. Mainly used to treat and prevent respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), they help maintain medical records in digital form in an efficient way.
Get a free sample copy of the report at – https://www.imarcgroup.com/smart-inhalers-market/requestsample
We regularly monitor the direct effect of COVID-19[feminine] in the market, as well as the indirect influence of associated industries. These observations will be incorporated into the report.
The market is mainly driven by the increasing prevalence of chronic respiratory diseases. Additionally, the increasing susceptibility to indoor air pollutants and particulates due to heavy usage of kerosene lamps and portable stoves is acting as a significant growth factor for the market. In addition, rising healthcare expenditure, drastic rise in air pollution levels, and extensive research and development (R&D) activities by major players are also creating a positive outlook for the market.
Key Players Included in the Global Smart Inhalers Market Research Report:
- 3M Company
- Adherium Limited
- AptarGroup Inc.
- Astra Zeneca plc
- Boehringer Ingelheim
- Cognita Laboratories
- GlaxoSmithKline plc
- Novartis AG
- OPKO Health Inc.
- Propeller Health (ResMed)
- Sensirion SA
- Teva Pharmaceutical Industries Ltd.
- Vectura Group Limited (Philip Morris International Inc.)
Do you know more information, contact our analyst at– https://www.imarcgroup.com/smart-inhalers-market
Key Market Segmentation:
Breakdown by product:
- dry powder inhaler
- metered dose inhaler
Break by indication:
- Chronic Obstructive Pulmonary Disease (COPD)
Breakdown by distribution channel:
- Hospital pharmacies
- Retail pharmacies
- Online stores
Breakdown by region:
- North America (USA, Canada)
- Asia-Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Others)
- Latin America (Brazil, Mexico, others)
- Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Others)
Table of Contents of Smart Inhalers Market Research Report:
- Scope and methodology
- Global smart inhaler market
- SWOT analysis
- Value chain analysis
- Price analysis
- Competitive landscape
Browse more reports by IMARC group:
Who we are:
The IMARC Group is a leading market research firm providing management strategies and market research worldwide. We partner with clients across all industries and geographies to identify their most important opportunities, address their most critical challenges and transform their businesses.
IMARC’s information products include major business, scientific, economic and technological developments for business leaders in pharmaceutical, industrial and high-tech organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverages, travel and tourism, nanotechnology and new processing methods are at the top of the list. company expertise.
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 United States
E-mail: [email protected]
Such. :(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe:- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800